Clinical trial
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple…
NCT00400686 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00400686 |
|---|---|
| Title | Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma |
| Official title | A Single Institution, Open-Label, Nonrandomized Pilot Study of High Dose Epoetin Alfa Administered Once a Week in Patients With Multiple Myeloma: Its Effects on Hemoglobin, Blood Transfusion Requirements and Quality of Life |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Anemia, Multiple Myeloma, Plasma Cell Neoplasm |
| Intervention type | Biological |
| Interventions | epoetin alfa |
| Enrollment | 31 |
| Start date | Sep 1, 2003 |
| Primary completion | Jan 1, 2009 |
| Completion | Aug 1, 2013 |
| First posted | Nov 17, 2006 |
| Last update posted | Feb 22, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: